Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs Epidural Blood Patch for Postdural Puncture Headache
NCT06271486Phase 3Completed
- Sponsor
- Al-Azhar University
- Start
- Feb 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pregabalin in post-dural puncture headache (PDPH) (3 arms), sponsored by Al-Azhar University. Primary endpoint: Incidence of complete relief at 48 hours. Started Feb 2024; status: completed.
02
Drugs
pregabalin
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT06271486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06271486.